[Featured Stock] Cellumed, CB Investors Positive Outlook on Secondary Battery New Business

Cellumed's stock price is on the rise. News that the company is pursuing a new business related to secondary batteries appears to be influencing the stock price.

At 10:38 a.m. on the 6th, Cellumed was trading at 5,190 KRW, up 3.8% from the previous trading day.

Yoo In-su, CEO of Cellumed, said in an interview with a media outlet, "We will secure the domestic market first and then leap forward as a secondary battery platform company."

Cellumed has primarily focused on the bio-material business using human-derived biomaterials. Recently, it has been pursuing various secondary battery-related businesses, including ▲mass production and distribution of replaceable secondary battery packs ▲production and sales of electric two-wheelers ▲standard battery pack-compatible battery exchange station business.

Cellumed expects to establish the foundation for its new secondary battery business this year and anticipates generating significant sales starting next year. The company plans to sign main contracts with overseas partners and build mass production factories through new investments. It also plans to sequentially obtain various permits and approvals necessary for the business, expecting to achieve visible performance results in the near future.

In the interview, CEO Yoo said, "Investors are also viewing the new business positively," adding, "Recently, most convertible bond (CB) investors exercised their conversion rights due to positive outlooks and expectations related to the secondary battery new business, thereby becoming long-term investors."